Reuters logo
BRIEF-Rui Kang Pharmaceutical Group Investments appoints Liu Xiaolin as chairman
August 28, 2017 / 1:41 PM / 2 months ago

BRIEF-Rui Kang Pharmaceutical Group Investments appoints Liu Xiaolin as chairman

Aug 28 (Reuters) - Rui Kang Pharmaceutical Group Investments Ltd:

* Chan Ka Chung has resigned as chairman of board

* Liu Xiaolin, an executive director, has been appointed as chairman

* Chan Ka Chung has resigned as an executive director

* Cheung Wai Kwan has resigned as an executive director

* Leung Pak Hou Anson ceased to be chief executive officer of company Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below